167 related articles for article (PubMed ID: 11083889)
21. Results of a clinical trial of clinafloxacin versus imipenem/cilastatin for intraabdominal infections.
Solomkin JS; Wilson SE; Christou NV; Rotstein OD; Dellinger EP; Bennion RS; Pak R; Tack K
Ann Surg; 2001 Jan; 233(1):79-87. PubMed ID: 11141229
[TBL] [Abstract][Full Text] [Related]
22. Multicenter randomized trial comparing meropenem (1.5 g daily) and imipenem/cilastatin (2 g daily) in the hospital treatment of community-acquired pneumonia.
Bartoloni A; Strohmeyer M; Corti G; Buonomini MI; Franchino L; Romanelli G; Moretti AM; De Vizzi GB; Petraglia A; Mancini P; Atzeni R; Fogliani V; Giura R; Paradisi F
Drugs Exp Clin Res; 1999; 25(6):243-52. PubMed ID: 10713862
[TBL] [Abstract][Full Text] [Related]
23. Prospective randomized controlled study of ciprofloxacin versus imipenem-cilastatin in severe clinical infections.
Lode H; Wiley R; Höffken G; Wagner J; Borner K
Antimicrob Agents Chemother; 1987 Oct; 31(10):1491-6. PubMed ID: 3324956
[TBL] [Abstract][Full Text] [Related]
24. Levofloxacin in the empirical treatment of patients with suspected bacteraemia/sepsis: comparison with imipenem/cilastatin in an open, randomized trial.
Geddes A; Thaler M; Schonwald S; Härkönen M; Jacobs F; Nowotny I
J Antimicrob Chemother; 1999 Dec; 44(6):799-810. PubMed ID: 10590282
[TBL] [Abstract][Full Text] [Related]
25. [Meropenem (Merrem) vs imipenem/cilastatin in hospital treatment of intra-abdominal infections. A multicenter study].
Tonelli F
Minerva Chir; 1997 Mar; 52(3):317-26. PubMed ID: 9148225
[TBL] [Abstract][Full Text] [Related]
26. A post hoc subgroup analysis of meropenem versus imipenem/cilastatin in a multicenter, double-blind, randomized study of complicated skin and skin-structure infections in patients with diabetes mellitus.
Embil JM; Soto NE; Melnick DA
Clin Ther; 2006 Aug; 28(8):1164-1174. PubMed ID: 16982293
[TBL] [Abstract][Full Text] [Related]
27. Treatment of severe pneumonia in hospitalised patients. Results of a multicentre trial comparing i.v. ciprofloxacin with imipenem/cilastatin.
Snydman D; Fink M; Niederman M; Reinhart H
Drugs; 1995; 49 Suppl 2():439-41. PubMed ID: 8549393
[No Abstract] [Full Text] [Related]
28. Piperacillin/tazobactam in the treatment of Klebsiella pneumoniae infections in neonates.
Pillay T; Pillay DG; Adhikari M; Sturm AW
Am J Perinatol; 1998 Jan; 15(1):47-51. PubMed ID: 9475688
[TBL] [Abstract][Full Text] [Related]
29. Clinical outcome of nosocomial pneumonia following imipenem/cilastatin therapy.
Rapp RP; Young B; Bertch K; Tibbs P; Foster TS
Drug Intell Clin Pharm; 1987 Mar; 21(3):272-6. PubMed ID: 3471433
[TBL] [Abstract][Full Text] [Related]
30. Treatment of acute bacterial exacerbations of chronic obstructive pulmonary disease in hospitalised patients--a comparison of meropenem and imipenem/cilastatin. COPD Study Group.
Hamacher J; Vogel F; Lichey J; Kohl FV; Diwok K; Wendel H; Lode H
J Antimicrob Chemother; 1995 Jul; 36 Suppl A():121-33. PubMed ID: 8543488
[TBL] [Abstract][Full Text] [Related]
31. [Treatment of respiratory tract infections with imipenem/cilastatin in critical patients with respiratory insufficiency].
Unertl K; Ruckdeschel G; Forst H; Lenhart FP
Infection; 1986; 14 Suppl 2():S176-80. PubMed ID: 3759253
[TBL] [Abstract][Full Text] [Related]
32. [Treatment of bronchopulmonary infections in patients during artificial respiration with imipenem/cilastatin].
Unertl K; Lenhart FP; Ruckdeschel G
Immun Infekt; 1986 Nov; 14(6):229-31. PubMed ID: 3100428
[TBL] [Abstract][Full Text] [Related]
33. Piperacillin/tazobactam vs imipenem/cilastatin in the treatment of nosocomial pneumonia--a double blind prospective multicentre study.
Schmitt DV; Leitner E; Welte T; Lode H
Infection; 2006 Jun; 34(3):127-34. PubMed ID: 16804655
[TBL] [Abstract][Full Text] [Related]
34. A multicenter, randomized controlled clinical study on biapenem and imipenem/cilastatin injection in the treatment of respiratory and urinary tract infections.
Jia B; Lu P; Huang W; Li C; Huang A; Zhou X; Zhang W; Wu G; Zhang G
Chemotherapy; 2010; 56(4):285-90. PubMed ID: 20714145
[TBL] [Abstract][Full Text] [Related]
35. Nosocomial Acinetobacter pneumonia: Treatment and prognostic factors in 356 cases.
Özvatan T; Akalın H; Sınırtaş M; Ocakoğlu G; Yılmaz E; Heper Y; Kelebek N; İşçimen R; Kahveci F
Respirology; 2016 Feb; 21(2):363-9. PubMed ID: 26635315
[TBL] [Abstract][Full Text] [Related]
36. Effects of parenterally administered ciprofloxacin in a murine model of pulmonary Pseudomonas aeruginosa infection mimicking ventilator-associated pneumonia.
Kaneko Y; Yanagihara K; Kuroki M; Ohi H; Kakeya H; Miyazaki Y; Higashiyama Y; Hirakata Y; Tomono K; Kadota JI; Kohno S
Chemotherapy; 2001 Dec; 47(6):421-9. PubMed ID: 11786657
[TBL] [Abstract][Full Text] [Related]
37. Cost-minimization analysis of piperacillin/tazobactam versus imipenem/cilastatin for the treatment of serious infections: a Canadian hospital perspective.
Marra FO; Frighetto LO; Marra CA; Sleigh KM; Stiver HG; Bryce EA; Reynolds RP; Jewesson PJ
Ann Pharmacother; 1999 Feb; 33(2):156-62. PubMed ID: 10084409
[TBL] [Abstract][Full Text] [Related]
38. Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia.
Freire AT; Melnyk V; Kim MJ; Datsenko O; Dzyublik O; Glumcher F; Chuang YC; Maroko RT; Dukart G; Cooper CA; Korth-Bradley JM; Dartois N; Gandjini H;
Diagn Microbiol Infect Dis; 2010 Oct; 68(2):140-51. PubMed ID: 20846586
[TBL] [Abstract][Full Text] [Related]
39. Bacteremia caused by Elizabethkingia meningoseptica in a mechanically ventilated patient successfully treated with imipenem-cilastatin and ciprofloxacin.
Chen CH; Lin CH; Lin JS
Rev Inst Med Trop Sao Paulo; 2017 Jun; 59():e26. PubMed ID: 28591254
[No Abstract] [Full Text] [Related]
40. Biapenem versus imipenem/cilastatin in the treatment of complicated intra-abdominal infections: report from a Swedish Study Group.
Brismar B; Akerlund JE; Sjöstedt S; Johansson C; Törnqvist A; Bäckstrand B; Bång H; Andåker L; Gustafsson PO; Darle N; Angerås M; Falk A; Tunevall G; Kasholm-Tengve B; Skau T; Nyström PO; Gasslander T; Hagelbäck A; Olsson-Liljequist B; Eklund AE; Nord CE
Scand J Infect Dis; 1996; 28(5):507-12. PubMed ID: 8953683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]